Dadoo Rajeev 4
4 · ARS Pharmaceuticals, Inc. · Filed Jun 28, 2023
Insider Transaction Report
Form 4
Dadoo Rajeev
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-27+40,000→ 40,000 totalExercise: $6.50Exp: 2033-06-26→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.